Hero image

Research

We run to, not from, the world’s biggest health challenges.

The journey to invention and discovery is guided by science – and inspired by patients

Our purpose is to save and improve lives for generations. Our strategy is simple: We follow the science. The path to discovery is often unclear, but we are tireless in seeking solutions for some of the world’s most difficult health challenges.

Our work in numbers

16.7K

people employed in research and development

422M

people reached through our major programs and partnerships

$13.6B

invested in R&D in 2020

We address the world’s most difficult health challenges, following world-class science

Hero_RGB_Discovery-Blue
Discovery & development

Step inside MSD Research Laboratories (MRL) where our quest to save and improve lives through research and development begins

B5 - Our pipeline__
Pipeline

We’re focused on inventing new medicines and vaccines to help more people

Father playing with young son at breakfast table

Our commitment to patients is unwavering

As long as there are still patients in hospitals, doctors and nurses desperate to add years to the lives of their patients, and a world where treatments aren’t accessible to all, we will be here, fighting with all we have to deliver more, sooner.

Invention begins here

Our scientists are applying the latest groundbreaking research technologies and revolutionizing how we discover and develop medicines and vaccines

View our stories

Our first-quarter 2021 financial results

MSD announced first-quarter sales of $12.1 billion, in-line with first-quarter 2020. Excluding the impact from foreign exchange, sales declined 1%. The company anticipates full-year 2021 revenue range to be between $51.8 billion and $53.8 billion, including a positive impact from foreign exchange of less than 2%. Take a look at the infographic below for more […]

Read more

Next: Our first-quarter 2021 financial results

How we kept clinical trials on track amid COVID-19

MSD’s head of global clinical trial operations talks pivoting during a worldwide pandemic

See how

Next: How we kept clinical trials on track amid COVID-19

Our commitment to HIV treatments and prevention through the years

We continue to work at the forefront of the fight against HIV

Read more

Next: Our commitment to HIV treatments and prevention through the years

Why we’re excited to partner on Johnson & Johnson’s COVID-19 vaccine

Our company has teamed with Johnson & Johnson to ramp up vaccine production – here’s what it means

Read more

Next: Why we’re excited to partner on Johnson & Johnson’s COVID-19 vaccine

Our fourth-quarter and full-year 2020 financial results

MSD announced fourth-quarter worldwide sales of $12.5 billion – an increase of 5%, and full-year 2020 worldwide sales of $48.0 billion – an increase of 2%. Excluding the impact from foreign exchange, sales grew 4%. The company anticipates full-year 2021 worldwide sales to be between $51.8 billion and $53.8 billion, including a positive impact from […]

Read more

Next: Our fourth-quarter and full-year 2020 financial results

Previous
Next